Robert Wild to Lipids
This is a "connection" page, showing publications Robert Wild has written about Lipids.
Connection Strength
2.544
-
Role of Lipid Management in Women's Health Preventive Care. Obstet Gynecol Clin North Am. 2021 Mar; 48(1):173-191.
Score: 0.677
-
Dyslipidemia in pregnancy. Cardiol Clin. 2015 May; 33(2):209-15.
Score: 0.452
-
Women's Health Considerations for Lipid Management. Cardiol Clin. 2015 May; 33(2):217-31.
Score: 0.452
-
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011 Mar 01; 95(3):1073-9.e1-11.
Score: 0.336
-
Lipids and Women's Health: Recent Updates and Implications for Practice. J Womens Health (Larchmt). 2019 06; 28(6):752-760.
Score: 0.141
-
Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med. 1995 Jan 16; 98(1A):27S-32S.
Score: 0.111
-
Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance. Am J Obstet Gynecol. 1992 Apr; 166(4):1191-6; discussion 1196-7.
Score: 0.091
-
Lipoprotein lipids in women with androgen excess: independent associations with increased insulin and androgen. Clin Chem. 1990 Feb; 36(2):283-9.
Score: 0.079
-
Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1985 Nov; 61(5):946-51.
Score: 0.059
-
Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group. Climacteric. 1998 Mar; 1(1):26-32.
Score: 0.034
-
Metabolic aspects of polycystic ovary syndrome. Semin Reprod Endocrinol. 1997 May; 15(2):105-10.
Score: 0.032
-
Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study. J Clin Lipidol. 2016 Jul-Aug; 10(4):833-841.
Score: 0.030
-
Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group. Obstet Gynecol. 1994 Dec; 84(6):987-95.
Score: 0.027
-
Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study. J Womens Health (Larchmt). 2004 Mar; 13(2):155-63.
Score: 0.013
-
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab. 2000 Jan; 85(1):214-8.
Score: 0.010